We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Manufacturers of in vitro diagnostics and low-risk medical devices could have an easier time registering their products in Brazil, thanks to a pair of resolutions proposed by Anvisa. Read More
CDRH is expecting a large number of devicemakers to take advantage of the Expedited Access PMA program proposed in draft guidance in April, center Director Jeffrey Shuren said during a Thursday webinar hosted by the Pew Charitable Trusts. Read More
The FDA’s recent approval of a gene-based diagnostic to improve blood matching before transfusions is just the first step for a technology that could vastly improve patient care, a panel of experts said recently. Read More